Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579163 · ClinicalTrials.gov registry record
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
A clinical trial of Leukemia and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 992
- Enrollment target
- 1
- Study location
NCT00579163 is a study of Leukemia and Breast Neoplasms that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 992 participants, above the 483-participant average among 233 other Leukemia trials with a reported enrollment target (105% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00579163, a study of Leukemia and Breast Neoplasms, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 992 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand the genetic causes of cancer and the inherited tendency to develop cancer. To accomplish this, blood specimens and/or saliva samples and/or tumor and normal tissue blocks from patients and families of patients with cancer will be collected. Blood specimens will be frozen and stored for analysis at a later date. Tumor tissue and normal tissue will be stored for analysis at a later date. In order to perform this study, patients and members of their families will be asked to provide blood samples and/or saliva samples. Individuals will be asked to provide a history of cancer in their relatives at the time the blood sample is given. No relatives will be contacted before they have been asked by a family member if they wish to participate in this study. If they do wish to participate, the relatives should indicate this by returning the "Family Member Consent for Contact Form" After we receive this form, arrangements may be made for the family member to send in a blood and/or saliva sample or to come in person to provide the sample to us. Except for family history, no medical information provided by one member of a family will be discussed with other family members. At the end of this form, we will also ask for your permission to be contacted in the future to discuss information about your health, additional research with your samples and/or certain research findings possibly related to your sample.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 992 participants |
| Start Date | 1994-12 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579163
The ClinicalTrials.gov registry entry for NCT00579163 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 992 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 483-participant average among 233 other Leukemia trials with a reported enrollment target (105% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Leukemia appearing as the primary indexed condition, and to 0 interventions.
NCT00579163 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00579163 about?
NCT00579163 is a clinical study titled "Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers". The purpose of this study is to better understand the genetic causes of cancer and the inherited tendency to develop cancer. To accomplish this, blood specimens and/or saliva samples and/or tumor and normal tissue blocks from patients and families of patients with cancer will be collected. Blood spe...
What is the current status of trial NCT00579163?
This trial is currently active not recruiting. The enrollment target is 992 participants. The study started on 1994-12. Estimated completion is 2026-12.
What conditions does trial NCT00579163 study?
This clinical trial studies the following conditions: Leukemia, Breast Neoplasms, Prostatic Neoplasms, Lymphoma, Non-Hodgkin, Ovarian Neoplasms.
Who is sponsoring clinical trial NCT00579163?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579163 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.